-
-
Overview
-
Please contact us at for specific academic pricing.
Background
MDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H]glycine binding) in vitro and in vivo.
-
- Properties
-
Overview